Award Recognizes Companies Who Achieve Highest Level of Safety
BEVERLY,Mass.,Feb. 3,2025 --Axcelis Technologies,Inc. (Nasdaq: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,has received the '2024 SK hynix CSO Safety and Health Award'. This prestigious award honors companies whose dedication and commitment in supplying products and services meet SK hynix's high standards for fab site and personal safety. The award was presented by Kim Youngsik,Chief Production Officer (CPO) of SK hynix,at a ceremony held at the SK hynix SUPEX Center in Icheon,Korea. Recipients are a select group of suppliers chosen for their exemplary performance in the areas of: Compliance with Regulations,Compliance with SK hynix policies,Improvements in the Company's EHS performance,and Reducing Overall Risks in the Semiconductor Supply Chain.
"It is an honor for Axcelis to receive the 2024 SK hynix CSO Safety and Health Award from SK hynix," said Russell Low,Axcelis' President and Chief Executive Officer. "This award is a testament to our dedication to customer collaboration and satisfaction,and our unwavering commitment to environmental sustainability and health and safety.
Vice President Kim Youngsik,commented,"Axcelis' exceptional commitment to health and safety has set them apart and is foundational to helping us achieve our priorities and serve our customers."
About Axcelis:
Axcelis (Nasdaq: ACLS),headquartered in Beverly,has been providing innovative,high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design,manufacture and complete life cycle support of ion implantation systems,one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
CONTACTS:
Press/Media Relations Contact:
Maureen Hart
Senior Director,Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: [email protected]
Axcelis Investor Relations Contact:
David Ryzhik
Senior Vice President,Investor Relations and Corporate Strategy
Telephone: (978) 787-2352
Email: [email protected]
Logo - /up/2025/0206/25020620014394205659.jpg
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors
Mar 5, 2025
HANGZHOU,China,March 2,2025-- HIKMICRO,the leading pioneer of technology exploration in the hunting market,unveiled its vision for the future at the IWA Outdoor Classics 2025 show in Nuremburg. HIKMIC
Mar 5, 2025
KUALA LUMPUR,Malaysia,March 3,2025--Lark,the all-in-one productivity platform trusted by leading homegrown brands in Southeast Asia,is proud to partner with leading home improvement retailer,MR D.I.Y.
Mar 5, 2025
WALNUT,Calif.,March 3,2025-- BioRes Dentech Inc. showcased its Ruizhi BLC Implant System at Dental South China 2025,a premium product line jointly launched by BioRes Dentech Inc. andBesmile,designed e
Mar 5, 2025